youtube_live
Q3 2026 earnings • released • EPS beat +7,92% • Revenue beat +1,34%
See resultschevron_right
A1ZN34:BVMF
Astrazeneca Plc Bdr
168,92 R$
0,00%
(0,00) 1D
30 հոկ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
166,50 R$
High
170,34 R$
Low
166,50 R$
Mkt. cap
289,79 մլրդ
Avg. vol.
1,06 հզր
Volume
2,87 հզր
52-wk high
190,40 R$
52-wk low
129,06 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
Open
166,50 R$
High
170,34 R$
Low
166,50 R$
Mkt. cap
289,79 մլրդ
Avg. vol.
1,06 հզր
Volume
2,87 հզր
52-wk high
190,40 R$
52-wk low
129,06 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
News stories
From web sources and news partners
WSJ
·
Less than a minute ago
AstraZeneca Launches $1.5 Billion Savings Plan to Fund Drug Pipeline
Yahoo Finance
·
6 ժամ առաջ
AstraZeneca: 3 Key Takeaways for Long-Term Investors
Investing.com
·
11 ժամ առաջ
Earnings call transcript: AstraZeneca beats Q3 2026 estimates, shares rise 7%
BeInCrypto
·
2 օր առաջ
COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 հզր
Founded06 ապր, 1999 թ.
HeadquartersՔեմբրիջ, Cambridgeshire, Միացյալ Թագավորություն
Sector-
Websiteastrazeneca.com